1. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. Issue 8 (26th March 2015) Authors: Spelman, T; Morris, M D; Zang, G; Rice, T; Page, K; Maher, L; Lloyd, A; Grebely, J; Dore, G J; Kim, A Y; Shoukry, N H; Hellard, M; Bruneau, J Journal: Journal of epidemiology and community health Issue: Volume 69:Issue 8(2015) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A165 SHORT INJECTION CESSATION EPISODES AS OPPORTUNITIES FOR HEPATITIS C PREVENTION. (1st March 2018) Authors: Fortier, E; Artenie, A; Jutras-Aswad, D; Roy, É; Grebely, J; Bruneau, J Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A172 C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOD AGONIST THERAPY (OAT). (1st March 2018) Authors: Conway, B; Dore, G J; Altice, F; Litwin, A; Grebely, J; Dalgard, O; Gane, E J; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, C; Gendrano, I; Huang, H; Chen, E; Nguyen, B; Wahl, J; Barr, E; Robertson, M; Platt, H Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A239 QUALITATIVE EVALUATION OF THE DECISIONS AND EXPERIENCES OF PEOPLE WHO INJECT DRUGS WHO RECEIVED A LIVER DISEASE ASSESSMENT AS PART OF A LIVER HEALTH PROMOTION CAMPAIGN: THE LIVERLIFE STUDY. (1st March 2018) Authors: Marshall, A D; Treloar, C; Dore, G J; Grebely, J Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. C‐EDGE CO‐STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT). Issue 4 (December 2016) Authors: Conway, B; Dore, G J; Altice, F; Litwin, A H; Grebely, J; Dalgard, O; Gane, E J; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, C‐Y1; Gendrano, I N; Huang, H‐C; Chen, E; Nguyen, B‐Y; Wahl, J; Barr, E; Robertson, M; Platt, H L Journal: Canadian Journal of Addiction Issue: Volume 7:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗